Show simple item record

dc.contributor.authorLuscieti, Sara
dc.contributor.authorTolle, Gabriele
dc.contributor.authorAranda, Jessica
dc.contributor.authorBenet Campos, Carmen
dc.contributor.authorRisse, Frank
dc.contributor.authorMorán, Érica
dc.contributor.authorMuckenthaler, Martina U.
dc.contributor.authorSánchez, Mayka
dc.date.accessioned2022-01-18T17:28:58Z
dc.date.available2022-01-18T17:28:58Z
dc.date.issued2013
dc.identifier.citationLuscieti, Sara; Tolle, Gabriele; Aranda, Jessica [et al.]. Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndrome. Orphanet Journal of Rare Diseases, 2013, 8, 30. Disponible en: <https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-8-30>. Fecha de acceso: 18 ene. 2022. DOI: 10.1186/1750-1172-8-30ca
dc.identifier.issn1750-1172ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/3079
dc.description.abstractBackground: Hereditary Hyperferritinaemia Cataract Syndrome (HHCS) is a rare autosomal dominant disease characterized by increased serum ferritin levels and early onset of bilateral cataract. The disease is caused by mutations in the Iron-Responsive Element (IRE) located in the 5′ untranslated region of L-Ferritin (FTL) mRNA, which post-transcriptionally regulates ferritin expression. Methods: We describe two families presenting high serum ferritin levels and juvenile cataract with novel mutations in the L-ferritin IRE. The mutations were further characterized by in vitro functional studies. Results: We have identified two novel mutations in the IRE of L-Ferritin causing HHCS: the Badalona +36C > U and the Heidelberg +52 G > C mutation. Both mutations conferred reduced binding affinity on recombinant Iron Regulatory Proteins (IPRs) in EMSA experiments. Interestingly, the Badalona +36C > U mutation was found not only in heterozygosity, as expected for an autosomal dominant disease, but also in the homozygous state in some affected subjects. Additionally we report an update of all mutations identified so far to cause HHCS. Conclusions: The Badalona +36C > U and Heidelberg +52 G > C mutations within the L-ferritin IRE only mildly alter the binding capacity of the Iron Regulatory Proteins but are still causative for the disease.en
dc.format.extent10ca
dc.language.isoengca
dc.publisherSpringer Natureca
dc.relation.ispartofOrphanet Journal of Rare Diseasesca
dc.relation.ispartofseries8;
dc.rightsThis article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttps://creativecommons.org/licenses/by/2.0
dc.subject.otherMutacionsca
dc.subject.otherFerro ferritina-Lca
dc.subject.otherSíndrome de cataracta d'hiperferritinèmia hereditàriaca
dc.subject.otherFerritina sèricaca
dc.subject.otherMetabolisme del ferroca
dc.subject.otherSistema regulador IRP/IREca
dc.subject.otherCataractes bilateralsca
dc.subject.otherHierro ferritina-Les
dc.subject.otherSíndrome de catarata de hiperferritinemia hereditariaes
dc.subject.otherFerritina séricaes
dc.subject.otherMetabolismo del hierroes
dc.subject.otherSistema regulador IRP/IREes
dc.subject.otherCataratas bilateraleses
dc.subject.otherFerro ferritin-Len
dc.subject.otherHereditary hyperferritinemia cataract syndromeen
dc.subject.otherSerum ferritinen
dc.subject.otherIron metabolismen
dc.subject.otherIRP / IRE regulatory systemen
dc.subject.otherBilateral cataractsen
dc.titleNovel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndromeen
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.subject.udc57ca
dc.identifier.doihttps://dx.doi.org/10.1186/1750-1172-8-30ca


Files in this item

 

This item appears in the following Collection(s)

Show simple item record

This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/2.0
Share on TwitterShare on LinkedinShare on FacebookShare on TelegramShare on WhatsappPrint